Abstract 24: Health Status Differences Between Early Invasive and Non Invasive Treatment Strategies in Patients With Peripheral Artery Disease: Insights From Portrait Registry
Suveen Angraal(University of Missouri–Kansas City), Kim G. Smolderen(Yale University), John A. Spertus(Saint Luke's Health System), Vittal Hejjaji(Saint Luke's Hospital), Carlos Mena‐Hurtado(Mount Sinai Hospital), Jan M.M. Heyligers(Elisabeth-TweeSteden Ziekenhuis), Rudolf Tutein Nolthenius(Albert Schweitzer Ziekenhuis), Herbert D. Aronow, J. Dawn Abbott(Brown University), Gregory L. Moneta(Oregon Health & Science University), Robert Fitridge(Royal Adelaide Hospital), William R. Hiatt(University of Colorado Denver), Peter Soukas(Northwestern University), Laith Derbas, Christopher J. White(Ochsner Medical Center), Manesh R. Patel(Duke University)
Cited by 0
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
(untitled)
|Edinburgh Research Explorer (University of Edinburgh)|0|2.3k
Global vascular guidelines on the management of chronic limb-threatening ischemia
|Journal of Vascular Surgery|2019|1.9k